Cargando…
Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity
BACKGROUND: Adipocyte renewal from preadipocytes occurs throughout the lifetime and contributes to obesity. To date, little is known about the mechanisms that control preadipocyte proliferation and differentiation. Prokineticin-2 is an angiogenic and anorexigenic hormone that activate two G protein-...
Autores principales: | Szatkowski, Cécilia, Vallet, Judith, Dormishian, Mojdeh, Messaddeq, Nadia, Valet, Phillippe, Boulberdaa, Mounia, Metzger, Daniel, Chambon, Pierre, Nebigil, Canan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852222/ https://www.ncbi.nlm.nih.gov/pubmed/24324673 http://dx.doi.org/10.1371/journal.pone.0081175 |
Ejemplares similares
-
Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions
por: Dormishian, Mojdeh, et al.
Publicado: (2013) -
Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development
por: Arora, Himanshu, et al.
Publicado: (2016) -
Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells
por: Qureshi, Rehana, et al.
Publicado: (2017) -
Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases
por: Nebigil, Canan G.
Publicado: (2017) -
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases
por: Vincenzi, Martina, et al.
Publicado: (2023)